Document is current
Any future updates will be listed below
-
Authors
Bartley, Nicci https://orcid.org/0000-0001-9052-1616
Davies, Grace https://orcid.org/0000-0001-7867-3780
Butow, Phyllis https://orcid.org/0000-0003-3562-6954
Napier, Christine E. https://orcid.org/0000-0001-8009-7735
Schlub, Tim https://orcid.org/0000-0001-7746-9649
Ballinger, Mandy L. https://orcid.org/0000-0002-9706-0514
Thomas, David M. https://orcid.org/0000-0002-2527-5428
Juraskova, Ilona https://orcid.org/0000-0001-9396-4113
Meiser, Bettina https://orcid.org/0000-0002-5086-0784
Best, Megan C. https://orcid.org/0000-0003-1570-8872
-
Funding
Funding for this research was provided by:
National Health and Medical Research Council (1124749, 1121630, 1078523, 1104364)
Cancer Institute NSW (MB00352, CDF171109)
- License Information
-
More Information
Article History
Received: 10 December 2020
Accepted: 20 May 2021
First Online: 25 May 2021
Declarations
:
: This article reports the quantitative baseline results examining the demographic and attitudinal factors associated with FCR/O. Ethics approval was obtained from Human Research Ethics Committees at St Vincent’s Hospital, Sydney, Australia (HREC/16/SVH/24).
: Informed consent was obtained from all induvial participants included in the study.
: Not applicable.
: BM has a remunerated consultant role with the company AstraZeneca with respect to an unrelated project. The other authors declare no conflicts of interest.
